Today, the FDA issued an emergency use authorization for the drug baricitinib, in combination with remdesivir, for the treatment of COVID-19 in hospitalized adults and pediatric patients 2+ years requiring supplemental oxygen, invasive mechanical ventilation, or ECMO.
Read more: Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19